A Systematic Review of the Validity and Reliability of the Patient-Determined Disease Steps Scale

Ruth Ann Marrie; Caitlin McFadyen; Lauren Yaeger; Amber Salter

doi:10.7224/1537-2073.2021-102

A Systematic Review of the Validity and Reliability of the Patient-Determined Disease Steps Scale

Int J MS Care. 2023 Jan-Feb;25(1):20-25. doi: 10.7224/1537-2073.2021-102. Epub 2022 Jul 5.

Authors

Ruth Ann Marrie^{1

2}, Caitlin McFadyen¹, Lauren Yaeger³, Amber Salter⁴

Affiliations

¹ Department of Internal Medicine (RAM, CM), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
² Department of Community Health Sciences (RAM), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
³ Bernard Becker Medical Library, Washington University School of Medicine, St. Louis, MO, USA (LY).
⁴ Section of Statistical Planning and Analysis, Department of Neurology, University of Texas Southwestern University, Dallas, USA (AS).

Abstract

Background: The Patient-Determined Disease Steps (PDDS) scale is a patient-reported measure of disability used by at least 3 North American multiple sclerosis (MS) registries. We conducted a systematic review of the psychometric properties of the PDDS scale as part of a harmonization effort related to disability measures used in MS registries.

Methods: We searched the EMBASE, Ovid Medline, Scopus, Cochrane Database of Systematic Reviews, CENTRAL, CINAHL Plus, and ClinicalTrials.gov databases from database inception through July 28, 2020. Two reviewers independently screened abstracts and full-text reports for study inclusion and data extraction and assessed study quality and risk of bias. We included studies that assessed the validity or reliability of the PDDS scale. We conducted a meta-analysis to quantitatively summarize the findings.

Results: From the 2476 abstracts screened, 234 articles underwent full-text review, of which 5 met the inclusion criteria. These studies assessed criterion validity, construct validity, and test-retest reliability. In all studies, criterion validity was assessed by correlating the PDDS scale score with the Expanded Disability Status Scale score (pooled r = 0.73; 95% CI, 0.66-0.79). Test-retest reliability was high (pooled intraclass correlation coefficient = 0.96; 95% CI, 0.92-0.99).

Conclusions: In this systematic review, the PDDS scale demonstrated criterion and construct validity for assessing disability in individuals with MS who have mild to moderate disabilities. This review also supports the test-retest reliability of the PDDS scale, although further studies with larger samples are needed.

Keywords: Patient Determined Disease Steps; multiple sclerosis; reliability; systematic review; validity.

Grants and funding

FUNDING/SUPPORT: This study was funded by the National Multiple Sclerosis Society (SI-1907-34399). Dr Marrie is supported by the Waugh Family Chair in Multiple Sclerosis and a research chair from Research Manitoba. Dr Salter is supported by a Biostatistics/Informatics Junior Faculty Award from the National Multiple Sclerosis Society. Dr Marrie receives research funding from Canadian Institutes of Health Research, the MS Society of Canada, the MS Scientific Research Foundation, the National MS Society, Crohn’s and Colitis Canada, the US Department of Defense, the Arthritis Society, and the Consortium of Multiple Sclerosis Centers (CMSC).